Latest News about Phase 1 Trial
Recent news which mentions Phase 1 Trial
Phathom Pharma's Vonoprazan Inhibits Gastric Acid In Healthy Volunteers
September 27, 2021
Tickers
PHAT
From Benzinga
Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder
September 27, 2021
Tickers
RARE
From Benzinga
Why Did ASLAN Pharma Shares Plunge Despite Positive Atopic Dermatitis Trial Data?
September 27, 2021
Tickers
ASLN
From Benzinga
Kids Suffer Adverse Reactions In Applied Genetic's Color Blindness Gene Therapy Trial
September 24, 2021
Tickers
AGTC
From Benzinga
GlycoMimetics' Lead Candidate Data Published In An Online Journal
September 24, 2021
Tickers
GLYC
From Benzinga
TFF Pharma's Inhaled Tacrolimus Powder Moves Closer To Phase 2 In Lung Transplantation
September 23, 2021
Tickers
TFFP
From Benzinga
Solid Biosciences Stock Gains After Duchenne Dystrophy Gene Therapy Data
September 23, 2021
Tickers
SLDB
From Benzinga
Investors Cheer Onconova's Rigosertib Combo Data In Lung Cancer Setting
September 22, 2021
From Benzinga
Stoke Therapeutics Posts Encouraging Interim Safety Data From Early-Stage Dravet Syndrome Trial
September 21, 2021
Tickers
STOK
From Benzinga
Oric Pharma To Launch Human Trial For CD73 Inhibitor Program In Q4
September 21, 2021
Tickers
ORIC
From Benzinga
Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO
September 21, 2021
Tickers
APRE
From Benzinga
Syros Posts Updated Data From CDK7 Inhibitor In Various Solid Tumor Settings
September 20, 2021
Tickers
SYRS
From Benzinga
Mirati Showcases New KRAS Drug Data In Colorectal Cancer At ESMO
September 20, 2021
From Benzinga
Why Are Synlogic Shares Moving Higher Premarket Monday?
September 20, 2021
Tickers
SYBX
From Benzinga
Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation
September 20, 2021
Tickers
VSTM
From Benzinga
Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer
September 20, 2021
From Benzinga
Janssen Shares Erdafitinib Combo Therapy Data In Bladder Cancer
September 17, 2021
Tickers
JNJ
From Benzinga
TCR2 Therapeutics Stock Plunges On Safety Signals From Gavo-cel Solid Tumor Trial
September 17, 2021
Tickers
TCRR
From Benzinga
Deciphera Presents New Data Across Pipeline At ESMO Congress
September 17, 2021
Tickers
DCPH
From Benzinga
From Benzinga
Gritstone Presents Data From Individualized Neoantigen Immunotherapy In Colorectal Cancer
September 17, 2021
From Benzinga
Biomea Fusion To Start Early-Stage Leukemia Setting Trial With BMF-219
September 16, 2021
Tickers
BMEA
From Benzinga
NGM Bio Presents Preliminary Data From NGM120 Solid Tumor Trial
September 16, 2021
Tickers
NGM
From Benzinga
Intellia To Test CRISPR-Engineered TCR-T Cell Candidate In Acute Myeloid Leukemia Patients
September 16, 2021
Tickers
NTLA
From Benzinga
Athenex Shares Are Trading Higher On Positive Oral Paclitaxel Data From Solid Tumor Trial
September 16, 2021
From Benzinga
Silverback Therapeutics Presents Initial Safety Data From Solid Tumor Combo Therapy Trial
September 16, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
